Total Funding
23
11
Total FundingSeries B raised
Growth Score 23 in past quarter
-3 pts
Heat Score 11 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
528221
Amoy Diagnostic focuses on molecular diagnostics for oncology precision medicine.
- Zheng Limou: Founder, President & CEO
- Anthony Marotta: Medical Director & North America
About the Company
Amoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx has a portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx's core product categories include single gene testing kits, multi-gene
testing panels, NGS panels, and NGS analytical systems.
